Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
BMC Cancer|January 20, 2017
High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resectionJohann von Felden, Denise Heim, Kornelius Schulze, et al.
BMC Gastroenterology|October 17, 2020
Perforation of the ascending colon during implantation of an indwelling peritoneal catheter: a case reportMaria Paparoupa, Henning Wege, Anna Creutzfeldt, et al.
Oncotarget|November 23, 2017
Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resectionJohann von Felden, Kornelius Schulze, Till Krech, et al.
Molecular Vision|January 20, 2011
SU5416 induces premature senescence in endothelial progenitor cells from patients with age-related macular degenerationMichelle Thill, Marc J Berna, Frank Kunst, et al.
Visceral Medicine|May 13, 2021
Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World CohortJohann von Felden, Kathrin Karkmann, Harald Ittrich, et al.
Cancers|June 2, 2021
Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis PatientsThorben Fründt, Linda Krause, Elaine Hussey, et al.
Zeitschrift Fur Gastroenterologie|October 20, 2021
[The use of immuno-oncologic therapy in hepatocellular carcinoma in the context of liver transplantation. An interdisciplinary benefit/risk assessment]Arndt Vogel, Martina Sterneck, Florian Vondran, et al.
Oncotarget|August 5, 2016
Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress responseDenise Heim, Ines Gil-Ibanez, Johannes Herden, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse modelDaniel Benten, Gunhild Keller, Alexander Quaas, et al.
Frontiers in Oncology|November 28, 2022
Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinomaThorben Fründt, Johann von Felden, Jenny Krause, et al.
Pageof 8